Established in December 2017, Jinan Hongwan Biotechnology Co., Ltd. (hereinafter referred to as "Hongwan Technology") is a supplier of pharmaceutical intermediates and APIs for several large pharmaceutical companies in China now, and has established cooperative mode of joint research and development and supporting production with Qilu Pharmaceutical Co., Ltd. At present, our company is dedicated to the development of advanced pharmaceutical intermediates and new biopharmaceutical materials industries, and is committed to the research and development of new drugs, as well as related industry chain operations of supporting production of pharmaceutical intermediates and APIs.

Under the supports of many scientific research platforms such as Oxford University, Qilu University of Technology, Shandong Academy of Sciences, Qilu Pharmaceutical Co., Ltd., and Shandong Academy of Pharmaceutical Sciences, our company owns outstanding R&D capabilities and management level. Owing to a number of high-level R&D personnel in R&D center, we have good ability to fully meet the requirements of current R & D works; moreover, we have a 1,000 square meters of organic synthesis laboratory, which is equipped with complete testing equipment.

Now, our company is in a period of rapid development, and we establish close cooperation of industry-university-research with with many universities and research institutes such as Shandong University and Qilu University of Technology (Shandong Academy of Sciences); we are going to provide products for the these universities for the purposes of scientific research exploration, and then the establish cooperative relations of collaborative transformation of projects.